The Japanese encephalitis vaccine is given as a two-dose course, with doses administered 28 days apart. A booster is recommended one year after the primary course for those who remain at ongoing risk, with further boosters every three years for continued exposure. The only Japanese encephalitis vaccine licensed in the UK is Ixiaro, which is suitable for adults and children aged two months and over. Vaccination should ideally be completed at least one week before potential exposure. At Perfect Meds, our expert pharmacists can assess your risk and administer the full course in advance of your departure.
The Japanese encephalitis vaccine is recommended for travellers visiting rural or agricultural areas of Asia where the Japanese encephalitis virus is present. It is particularly important for those spending a month or more in endemic areas during the transmission season. Shorter trips can also carry meaningful risk where the itinerary involves outdoor activities in rural settings. The vaccine is the only reliable means of protection against a disease for which there is no specific antiviral treatment. From reviewing your full travel itinerary to advising on the suitability of the Japanese encephalitis vaccine and administering the complete course, our expert pharmacists at Perfect Meds provide a comprehensive and convenient service tailored to every individual traveller.
Book now to arrange your Japanese encephalitis vaccination at Perfect Meds.
What is Japanese Encephalitis?
Japanese encephalitis is a serious viral infection of the brain caused by the Japanese encephalitis virus. It belongs to the Flavivirus family, which also includes dengue, Zika, and yellow fever. The virus is transmitted to humans through the bites of infected Culex mosquitoes. These mosquitoes breed in rice paddies and other irrigated agricultural environments. They feed predominantly during the evening and night hours.
Despite its name, Japanese encephalitis is now rare in Japan due to widespread vaccination programmes. The highest burden of disease is found in South and Southeast Asia, East Asia, and parts of the Western Pacific region. The virus circulates in a transmission cycle involving pigs as amplifying hosts and wading birds as reservoir hosts. Humans are incidental dead-end hosts who do not contribute to ongoing transmission. This means the risk of infection is most closely associated with proximity to pig farming and rice cultivation.
Japanese encephalitis is the leading cause of viral encephalitis in Asia. The vast majority of people who are infected experience no symptoms at all or only mild non-specific illness. However, a small proportion develop severe disease. In those who develop clinical encephalitis, the case fatality rate is significant. Among survivors, a large proportion are left with lasting neurological or psychiatric problems. There is no specific antiviral treatment once infection has occurred. Prevention through vaccination is therefore the only reliable means of protection.
Where is Japanese Encephalitis Found?
Japanese encephalitis is endemic across a wide geographic area spanning much of Asia and the Western Pacific. Understanding which countries and regions carry a meaningful risk is essential for determining whether vaccination is appropriate for a given travel itinerary.
- South Asia: India, particularly rural areas, Nepal, Sri Lanka, Bangladesh, and Pakistan in limited areas.
- Southeast Asia: Thailand, Vietnam, Cambodia, Laos, Myanmar, Malaysia, Indonesia, the Philippines, and Timor-Leste.
- East Asia: China, Japan in rural areas, South Korea, and Taiwan.
- The Western Pacific: Papua New Guinea, parts of Australia including the Torres Strait Islands and far north Queensland, and various Pacific Island territories.
The transmission season varies by region. In tropical regions near the equator, transmission can occur year-round. In more temperate regions such as northern China, Korea, Japan, and Nepal, transmission is seasonal and typically occurs between June and October. In South and Southeast Asia, transmission generally peaks during and after the rainy season. The risk is considerably lower in urban environments without proximity to agricultural land. Travellers who remain exclusively in major cities are generally considered to be at low risk.
Who Should Have the Japanese Encephalitis Vaccine?
The decision to vaccinate against Japanese encephalitis requires a careful assessment of individual risk. This is based on the specific destination, the time of year, the duration of stay, and the planned activities. Current UKHSA and TravelHealthPro guidance provides a framework for this assessment. However, the final decision should always be made in consultation with a qualified travel health professional.
Travellers for Whom the Vaccine is Recommended
- Travellers spending a month or more in endemic rural or agricultural areas of Asia during the transmission season.
- Shorter-stay travellers whose itinerary involves significant outdoor exposure in rural or agricultural settings, including cyclists, hikers, campers, and field researchers.
- Travellers working or volunteering in agricultural, veterinary, or field research settings in endemic areas, particularly those near pigs or wading birds.
- Travellers making repeated trips to endemic regions who may accumulate significant cumulative exposure over time.
- Expatriates and long-term residents living in endemic areas of Asia.
- Travellers visiting known outbreak areas, regardless of trip duration.
- Laboratory workers who handle live Japanese encephalitis virus as part of their professional work.
Travellers at Lower Risk
Travellers who spend their entire trip in urban environments without visiting rural or agricultural areas are generally considered to be at very low risk. Vaccination is not routinely recommended for this group. However, if any part of an urban trip involves excursions to rural areas, even for a single day, the risk assessment changes and vaccination may become appropriate. A pharmacist at Perfect Meds can review your full itinerary and provide a clear, evidence-based recommendation tailored to your specific plans.
The Japanese Encephalitis Vaccination Schedule
The only Japanese encephalitis vaccine currently licensed in the UK is Ixiaro, manufactured by Valneva. It is an inactivated vaccine and cannot cause Japanese encephalitis infection. The standard two-dose course is suitable for adults and children aged three years and over. The paediatric schedule uses a half dose volume for children aged two months to under three years.
The standard schedule delivers the first dose on day zero and the second dose 28 days later. The full course should ideally be completed at least one week before potential exposure. For adults aged 18 to 65 who need faster protection, an accelerated schedule is available. This delivers both doses seven days apart. The accelerated schedule is licensed for adults aged 18 to 65 only. Use outside this age range is off-label and requires specialist assessment.
A booster dose is recommended for those who remain at ongoing risk. Current UKHSA guidance recommends a booster one year after the primary course. Further boosters are then recommended every three years for continued ongoing exposure. A single booster dose is all that is required for those returning to a Japanese encephalitis endemic area more than a year after completing their primary course, with no need to repeat the full two-dose course from scratch.
Japanese Encephalitis Vaccination Schedules
The table below provides a clear summary of the Japanese encephalitis vaccination schedules available at Perfect Meds, including dose timing, age group suitability, booster requirements, and key practical notes for each schedule.
| Schedule | Dose Timing | Age Group | Booster | Notes |
|---|---|---|---|---|
| Standard | 2 doses, 28 days apart | Adults and children aged 3 years and over | At 1 year if still at risk, then every 3 years | Complete at least 1 week before travel |
| Accelerated | 2 doses, 7 days apart | Adults aged 18 to 65 only (licensed) | At 1 year if still at risk, then every 3 years | Use outside licensed age range requires specialist assessment |
| Paediatric | 2 doses, 28 days apart (half dose volume) | Children aged 2 months to under 3 years | At 1 year if still at risk, then every 3 years | Half the adult dose volume per injection |
| Booster | Single dose | All ages following a completed primary course | Every 3 years for continued ongoing exposure | Recommended 1 year after primary course if still at risk |
Identifying the most appropriate Japanese encephalitis vaccination schedule for your specific trip requires a thorough assessment of your itinerary, health history, and the time available before departure. Contact us to book a consultation at Perfect Meds today and leave your appointment knowing exactly which schedule is right for you.
How Long Does the Japanese Encephalitis Vaccine Last?
Following completion of the standard two-dose primary course of Ixiaro, protection is considered to be established within one week of the second dose. For travellers who complete the course and then return to the UK without further exposure risk, the duration of protection from the primary course alone has not been fully defined by long-term studies. However, clinical trial data and post-marketing experience support meaningful protection for at least twelve to twenty-four months following the primary course.
For those who remain at ongoing risk, current UKHSA guidance recommends a booster dose one year after the primary course. Further boosters are then recommended every three years for continued ongoing exposure. For individuals who completed a primary course more than a year ago and are returning to a Japanese encephalitis endemic area, a single booster dose is recommended. There is no need to repeat the full two-dose course in this situation. Our pharmacists at Perfect Meds can review your vaccination history and advise on whether a booster is needed before your next trip.
Japanese Encephalitis and Children
Children travelling with their families to Japanese encephalitis endemic regions deserve particular attention in any travel health risk assessment. Ixiaro is licensed for use in children from two months of age. Children may be at heightened risk of Japanese encephalitis exposure for several reasons. They tend to play outdoors during the evening hours. They have closer contact with animals and the natural environment. They may also be less able to consistently apply mosquito repellent and comply with other protective measures.
The risk-benefit assessment for vaccinating children against Japanese encephalitis follows the same principles as for adults. The duration of stay, the specific areas to be visited, the planned activities, and the time of year are all relevant factors. For family trips involving extended rural stays, outdoor activities, or travel during the transmission season, vaccination of all eligible family members is strongly advisable. Parents should discuss the full travel itinerary with a travel health professional well in advance of departure. This allows sufficient time to complete the two-dose course before travel.
For children aged two months to under three years, the paediatric schedule uses a half dose volume of Ixiaro. The schedule is otherwise the same as for older children and adults. Parents should bring a record of any previous vaccinations their child has received to the appointment. Our pharmacists at Perfect Meds are experienced in providing travel health consultations for families and can advise on the most appropriate schedule for every member of the travel party.
Japanese Encephalitis Vaccine Safety and Side Effects
Ixiaro has been evaluated extensively in clinical trials and through post-marketing surveillance. It has a well-established safety profile across all age groups for which it is licensed. The vaccine is generally very well tolerated. The absence of nervous system tissue derived from mouse brains, used in older Japanese encephalitis vaccine formulations, means that the neurological adverse events associated with earlier vaccines are not a concern with Ixiaro.
Common Side Effects
- Soreness, tenderness, redness, or mild swelling at the injection site. This is the most frequently reported reaction and typically resolves within two to three days.
- Headache and fatigue following vaccination, usually short-lived and resolving without treatment.
- Mild fever, muscle aches, or flu-like symptoms in a smaller proportion of recipients, particularly following the first dose.
- In children, irritability, crying, and mild gastrointestinal symptoms such as loss of appetite are among the most common reactions.
- Serious allergic reactions are extremely rare. Recipients should remain at the vaccination centre for at least 15 minutes after each dose.
Who Can Have the Japanese Encephalitis Vaccine?
Ixiaro is suitable for most adults and children aged two months and over. It is safe for immunocompromised individuals, though the immune response may be reduced in this group. Those with a known severe allergy to any component of the vaccine, including alum and protamine sulphate, should discuss their suitability for vaccination with a healthcare professional before proceeding. Pregnant women should discuss the risk-benefit assessment of Japanese encephalitis vaccination with a healthcare professional. Data on the use of Ixiaro in pregnancy is limited. In situations where the risk of Japanese encephalitis exposure during pregnancy is considered significant, vaccination may be recommended.
The vaccinations recommended for your trip will depend entirely on where you are travelling and what you plan to do when you get there, making destination-specific advice an essential part of any pre-travel health preparation. Enter your destination below to find out which travel vaccines may be relevant for your specific itinerary, including whether the Japanese encephalitis vaccine should form part of your pre-travel health plan:
Mosquito Bite Prevention Alongside the Japanese Encephalitis Vaccine
The Japanese encephalitis vaccine is highly effective at reducing the risk of clinical disease. However, vaccination alone is not sufficient protection for travellers in high-risk environments. The same mosquitoes that transmit Japanese encephalitis virus can also transmit dengue fever and chikungunya. Mosquito bite prevention measures are therefore an essential and non-negotiable component of any travel health strategy for those visiting endemic regions.
The Culex mosquitoes responsible for Japanese encephalitis transmission are most active during the evening and night hours. This makes outdoor activities in the evenings the highest-risk time for exposure. Sleeping in unscreened or unprotected accommodation also carries a significant risk. Effective bite prevention during these peak hours is critical for minimising the risk of Japanese encephalitis and other vector-borne diseases.
- Apply a DEET-based insect repellent containing at least 50% DEET to all exposed skin during peak biting hours. Reapply regularly after sweating or swimming.
- Wear loose-fitting, light-coloured, long-sleeved clothing and long trousers during the evening and night to minimise exposed skin.
- Sleep under a permethrin-impregnated mosquito net, particularly in accommodation without adequate screening or air conditioning.
- Use insecticide sprays, coils, or plug-in devices in sleeping areas to reduce mosquito presence indoors.
- Avoid outdoor activities in rural or agricultural areas during peak biting times where possible, particularly near rice paddies, pig farms, or areas of standing water.
- Treat clothing and outdoor equipment with permethrin for additional protection during extended outdoor activities.
Getting the Japanese Encephalitis Vaccine at Perfect Meds
The Japanese encephalitis vaccine is not available on the NHS for travel purposes. It must be obtained through a private travel clinic or registered pharmacy. Perfect Meds offers the Japanese encephalitis vaccine as part of a comprehensive travel health service that assesses your complete itinerary and ensures you receive all the vaccinations appropriate for your trip.
Our expert pharmacists will begin with a thorough travel health assessment. This covers your full itinerary, including the specific regions to be visited, planned activities, type of accommodation, and the time of year. Your medical history and any existing vaccination records will also be reviewed. Based on this assessment, they will advise on whether the Japanese encephalitis vaccine is recommended for your trip and which schedule is most appropriate. The first dose can be administered in the same appointment as the consultation in most cases.
We recommend booking your travel health appointment at least six to eight weeks before your intended departure date. This allows sufficient time to complete the two-dose course and for immunity to develop fully before travel. If your departure is approaching, the accelerated schedule may be available for eligible adults, providing a minimum lead time of eight days before travel. Our pharmacists will advise on the most appropriate approach given the time available before departure.
At the end of your appointment, you will receive a written record of any vaccines administered. This will include the vaccine name, batch number, date of administration, and the recommended timing of your booster dose. Keeping this record is important for future travel health consultations and for any medical care you may need at home or abroad. Our pharmacists are also available to answer any questions you have after your appointment.
A thorough travel health assessment before visiting a Japanese encephalitis endemic region is the most reliable way to ensure your vaccination plan is appropriate for your itinerary and completed in time before departure. Call us to book a consultation at Perfect Meds today and take the most important step towards a safe and fully protected trip.
Frequently Asked Questions
These answers to the most common questions about the Japanese encephalitis vaccine will help you feel fully informed and confident before your vaccination appointment at Perfect Meds.
Do I need the Japanese encephalitis vaccine for a city break in Asia?
Travellers spending their entire trip in urban environments without visiting rural or agricultural areas are generally considered to be at very low risk and vaccination is not routinely recommended. However, if any part of the trip involves excursions to rural areas or outdoor activities in endemic settings, the risk assessment changes and vaccination may be appropriate.
Can I have the Japanese encephalitis vaccine at the same time as other travel vaccines?
Yes. Ixiaro can be administered alongside most other travel vaccines, including hepatitis A, hepatitis B, typhoid, rabies, and yellow fever, without any meaningful reduction in efficacy or increased risk of side effects. Combining multiple vaccinations in a single travel health appointment is safe, practical, and routinely done at Perfect Meds.
How soon before travel should I start the Japanese encephalitis vaccine course?
The standard two-dose course should be started at least 29 days before travel to allow both doses to be given 28 days apart and for immunity to develop fully before departure. For adults aged 18 to 65, the accelerated seven-day schedule provides a minimum lead time of eight days before travel, though earlier booking is always preferable.
What should I do if I missed my second dose of the Japanese encephalitis vaccine?
The second dose of Ixiaro should ideally be given 28 days after the first dose. It must be given no later than 60 days after the first dose to remain within the licensed schedule. Where the 60-day window has been exceeded, the second dose should still be administered rather than restarting the full course, as clinical evidence supports the validity of a delayed second dose beyond the licensed interval in most cases. A pharmacist or GP can advise on the most appropriate approach based on individual circumstances and the time elapsed since the first dose.
Is the Japanese encephalitis vaccine safe during pregnancy?
Data on the use of Ixiaro during pregnancy is limited, and the vaccine should generally be avoided unless the risk of Japanese encephalitis exposure is considered to outweigh any theoretical risk of vaccination. Pregnant women who must travel to high-risk endemic areas should discuss the risk-benefit assessment in detail with their GP or a travel health professional before making a decision.
Is the Japanese encephalitis vaccine available on the NHS?
The Japanese encephalitis vaccine is not available on the NHS for travel purposes and must be obtained through a private travel clinic or registered pharmacy such as Perfect Meds. Laboratory workers who handle live Japanese encephalitis virus professionally may be eligible for occupational health vaccination through their employer.
Japanese Encephalitis Vaccination at Perfect Meds
When it comes to protecting travellers visiting rural and agricultural areas of Asia, the Japanese encephalitis vaccine is among the most clinically important preventive measures available. For those at meaningful risk of exposure, the two-dose Ixiaro course is safe, effective, and well tolerated across all eligible age groups. Combined with consistent mosquito bite prevention measures, it gives travellers visiting high-risk environments the best possible protection against a disease for which there is no specific treatment once infection has occurred.
At Perfect Meds, our expert pharmacists are here to make accessing the Japanese encephalitis vaccine as straightforward as possible for every traveller. Whether you need a full primary course ahead of an upcoming trip, a booster following a previous course, or a comprehensive travel health review covering all the vaccinations your itinerary requires, we provide personalised, evidence-based advice in fast and convenient appointments. Book now to secure your Japanese encephalitis vaccination at Perfect Meds and set off on your Asian adventure fully protected and completely prepared.
Medical Disclaimer: The information provided in this article is intended for general informational purposes only and does not constitute medical advice. Individual circumstances vary, and you should always speak to a qualified medical professional or pharmacist before starting any vaccination, treatment, or health programme. If you have any concerns about your health or suitability for any vaccine, please consult your GP or a registered healthcare provider before proceeding.
